Latest Market News

ADX Energy Ltd is gearing up to resume flow testing at its Welchau-1 well in February 2026 and plans to drill three additional shallow gas wells in Upper Austria, targeting a combined prospective resource of 8.0 BCF.

Janus Henderson Investors has announced the distribution timetable for its Global Sustainable Equity Active ETF for the period ending December 2025, outlining key dates and reinvestment options for investors.

Structural Monitoring Systems Plc has removed director Ross Love following a Federal Court decision denying an injunction sought by Love and his associated company. The company continues to face ongoing legal proceedings amid serious workplace allegations.

Wingara AG Limited has arranged a $250,000 unsecured loan facility from NAOS Asset Management entities, featuring a convertible note option that could reshape its capital structure.

Kinetiko Energy has secured approval to trade on the North American OTCQB Market, aiming to boost investor access and liquidity as it advances its South African gas projects.

Chimeric Therapeutics has raised $8.4 million to fully fund its lead CHM CDH17 CAR-T Phase 1/2 trial through Phase 1, while initiating a strategic reset to sharpen focus and reduce costs.

Metgasco has pushed back the deadline for Vintage Energy’s commitment to acquire its stake in the Odin and Vali Gas Fields, extending the timeline while keeping the overall transaction completion date intact.

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Elevate Uranium has expanded its global uranium resource base to 169 million pounds of U3O8 through the strategic acquisition of the Napperby Uranium Project and complementary assets from Core Lithium. This move consolidates its Central Australian portfolio and leverages its proprietary U-pgrade™ beneficiation technology.

MRG Metals has completed the acquisition of the Garies Rare Earth Project, a high-grade, magnet-rich rare earth asset in South Africa, significantly boosting its critical minerals portfolio. The deal positions MRG for rapid development with a clear pathway to early cashflow and complements its existing projects in Mozambique and the Adriano–Fotinho corridor.

BCI Minerals has secured crucial environmental approvals to proceed with its optimized dredging strategy at the Mardie Salt Operation, setting the stage for first salt shipments by late 2026.

Invion Limited’s partner Hanlim Pharm, backed by South Korea’s government grant, has secured up to A$2 million in non-dilutive funding to advance preclinical studies of HL270 for oesophageal cancer, paving the way for human trials in Australia.